Antimicrobial Optimization in the ICU: Treating HABP/VABP in the Critically Ill Patient
Back to course
Asset Caption
The goal of this activity is to improve the knowledge and competence of health care providers about the diagnosis, treatment, and management of HABP/VABP in critically ill patients.
Learning Objectives:
-Describe the role of rapid diagnostics in HABP/VABP caused by MDR gram-negative infections
-Appropriately use new antimicrobial agents for both empiric and targeted therapy in MDR gram-negative HABP/VABP
-Identify strategies for managing critically ill patients with unique clinical scenarios, such as augmented or diminished renal clearance
-Implement effective approaches to antimicrobial stewardship and minimizing TTET
This program is supported by educational grants from AbbVie and Merck Sharp & Dohme Corp